Sundrug Revenue

Sundrug had revenue of 207.70B JPY in the quarter ending June 30, 2025, with 6.75% growth. This brings the company's revenue in the last twelve months to 814.94B, up 6.64% year-over-year. In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B with 6.66% growth.

Revenue (ttm)

814.94B

Revenue Growth

+6.64%

P/S Ratio

0.69

Revenue / Employee

114.06M

Employees

7,145

Market Cap

563.78B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	801.81B	50.03B	6.66%
Mar 31, 2024	751.78B	61.32B	8.88%
Mar 31, 2023	690.46B	41.73B	6.43%
Mar 31, 2022	648.73B	14.42B	2.27%
Mar 31, 2021	634.31B	16.54B	2.68%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,196.22B
Takeda Pharmaceutical Company	4,480.25B
HOYA Corporation	876.09B
Daiichi Sankyo Company	1,924.68B
Otsuka Holdings	2,401.70B
Terumo	1,037.94B
Astellas Pharma	1,944.99B
Shionogi &	440.50B

Revenue Rankings